Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 ...

Full Year 2024 Results Key Financial Results Revenue: US$3.50m (up 21% from ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024 Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to ...

CEPI is providing US$4.5 million to non-profit Fondazione Biotecnopolo di Siena (FBS) for proof-of-concept research that will ...

March 26, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture ...

March 26, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic”, "we”, "us”, "our”, or the "Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture ...

Dyadic International Inc. (DYAI) reported its fourth-quarter 2024 earnings, revealing a mixed financial performance. The company significantly exceeded revenue expectations, posting $3.5 million ...

英为财情Investing.com - Dyadic (NASDAQ: DYAI )星期三发布了第一季度的财报，数据显示，公司营收高于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.200，总营收为$3.5M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$1.1M，每股收益为$-0.070.